CD22 modulation alleviates amyloid β-induced neuroinflammation
Abstract Neuroinflammation is a crucial driver of multiple neurodegenerative diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Yet, therapeutic targets for neurodegenerative diseases based on neuroinflammation still warrant investigation....
Saved in:
Main Authors: | Yu Dong Mai, Qingqing Zhang, Cheuk Lim Fung, Shui On Leung, Chi Ho Chong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-025-03361-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01) -
Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflammation
by: Chaokai Yang, et al.
Published: (2025-01-01) -
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01) -
Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01) -
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease
by: Xueyan Liu, et al.
Published: (2025-11-01)